A novel treatment that uses a disintegrating matrix for sustained release of medication led to improvement in vision and reduced supplemental treatment in patients with diabetic macular edema, ...

Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...

Panelists discuss how emerging therapies—including TKIs, sustained-release implants, and gene therapy—may reduce treatment ...

Alert Mirati's Lung Cancer Drug Gets EU's Regulatory Backing Mirati Therapeutics said on Friday the European medicines regulator's panel has recommended approval of its treatment for a type of lung ...